John E. Mindur

John E. Mindur

Auto-generated profile, based on publicly available information

John E. Mindur

Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
CMCameron S. McAlpine
Cameron S. McAlpine
MKMáté G. Kiss
Máté G. Kiss
SRSara Rattik
Sara Rattik
SHShun He
Shun He
AVAnne Vassalli
Anne Vassalli
FSFilip K. Swirski
Filip K. Swirski

14 July 2021 in Nature
Verified
Journal Article
Closed access
PDF file
CMCameron S. McAlpine
Cameron S. McAlpine
JPJoseph Park
Joseph Park
AGAna Griciuc
Ana Griciuc
EKEunhee Kim
Eunhee Kim
SCSe Hoon Choi
Se Hoon Choi
FSFilip K. Swirski
Filip K. Swirski

4 October 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AAAtsushi Anzai
Atsushi Anzai
JCJennifer L. Choi
Jennifer L. Choi
SHShun He
Shun He
AFAshley M. Fenn
Ashley M. Fenn
MNManfred Nairz
Manfred Nairz
FSFilip K. Swirski
Filip K. Swirski
Myocardial infarction (MI) elicits massive inflammatory leukocyte recruitment to the heart. Here, we hypothesized that excessive leukocyte invasion leads to heart failure and death during acute myocardial ischemia. We found that shortly and transiently after onset of ischemia, human and mouse cardiac fibroblasts produce granulocyte/macrophage colony-stimulating factor (GM-CSF) that acts locally and distally to generate and recruit inflammatory and proteolytic cells. In the heart, fibroblast-derived GM-CSF alerts its neighboring myeloid cells to attract neutrophils and monocytes. The growth factor also reaches the bone marrow, where it stimulates a distinct myeloid-biased progenitor subset. Consequently, hearts of mice deficient in either GM-CSF or its receptor recruit fewer leukocytes and function relatively well, whereas mice producing GM-CSF can succumb from left ventricular rupture, a complication mitigated by anti–GM-CSF therapy. These results identify GM-CSF as both a key contributor to the pathogenesis of MI and a potential therapeutic target, bolstering the idea that GM-CSF is a major orchestrator of the leukocyte supply chain during inflammation.

30 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
SHShun He
Shun He
FKFlorian Kahles
Florian Kahles
SRSara Rattik
Sara Rattik
MNManfred Nairz
Manfred Nairz
CMCameron S. McAlpine
Cameron S. McAlpine
FSFilip K. Swirski
Filip K. Swirski

1 June 2015 in Current Opinion in Neurology
Verified
Journal Article
Closed access
SYSudhir K. Yadav
Sudhir K. Yadav
JMJohn E. Mindur
John E. Mindur
KIKouichi Ito
Kouichi Ito
SDSuhayl Dhib-Jalbut
Suhayl Dhib-Jalbut
Recent studies indicate a role for immune dysregulation in the pathogenesis of multiple sclerosis, an inflammatory demyelinating and degenerative disease of the central nervous system. This review addresses the current mechanisms of immune dysregulation in the development of multiple sclerosis, including the impact of environmental risk factors on immunity in both multiple sclerosis and its animal models. CD4 T-helper (Th) cells have long been implicated as the main drivers of pathogenesis of multiple sclerosis. However, current studies indicate that multiple sclerosis is largely a heterogeneous disease process, which involves both innate and adaptive immune-mediated inflammatory mechanisms that ultimately contribute to demyelination and neurodegeneration. Therefore, B cells, CD8 T cells, and microglia/macrophages can also play an important role in the immunopathogenesis of multiple sclerosis apart from proinflammatory CD4 Th1/Th17 cell subsets. Furthermore, increasing evidence indicates that environmental risk factors, such as Vitamin D deficiency, Epstein-Barr virus, smoking, Western diet, and the commensal microbiota, influence the development of multiple sclerosis through interactions with genetic variants of multiple sclerosis, thus leading to the dysregulation of immune responses. A better understanding of immune-mediated mechanisms in the pathogenesis of multiple sclerosis and the contribution of environmental risk factors toward the development of multiple sclerosis will help further improve therapeutic approaches to prevent disease progression.

21 September 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CMCameron S. McAlpine
Cameron S. McAlpine
MKMáté G. Kiss
Máté G. Kiss
FZFaris M. Zuraikat
Faris M. Zuraikat
DCDavid Cheek
David Cheek
GSGiulia Schiroli
Giulia Schiroli
FSFilip K. Swirski
Filip K. Swirski
A sleepless night may feel awful in its aftermath, but sleep’s revitalizing powers are substantial, perpetuating the idea that convalescent sleep is a consequence-free physiological reset. Although recent studies have shown that catch-up sleep insufficiently neutralizes the negative effects of sleep debt, the mechanisms that control prolonged effects of sleep disruption are not understood. Here, we show that sleep interruption restructures the epigenome of hematopoietic stem and progenitor cells (HSPCs) and increases their proliferation, thus reducing hematopoietic clonal diversity through accelerated genetic drift. Sleep fragmentation exerts a lasting influence on the HSPC epigenome, skewing commitment toward a myeloid fate and priming cells for exaggerated inflammatory bursts. Combining hematopoietic clonal tracking with mathematical modeling, we infer that sleep preserves clonal diversity by limiting neutral drift. In humans, sleep restriction alters the HSPC epigenome and activates hematopoiesis. These findings show that sleep slows decay of the hematopoietic system by calibrating the hematopoietic epigenome, constraining inflammatory output, and maintaining clonal diversity.